[
    {
        "file_name": "PACIRAPHARMACEUTICALS,INC.-A_RSTRATEGICLICENSING,DISTRIBUTIONANDMARKETINGAGREEMENT.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "\"Applicable Laws\" Shall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export, storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances Act, as amended (21 U.S.C. §801 et seq.), or as defined in attendant regulations promulgated under authorities granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having effect in any jurisdiction in the Territory;",
                "changed_text": "\"Applicable Laws\" Shall mean some laws, rules and regulations regarding the manufacture, packaging, labeling, import, export, storage, distribution, representation, promotion, marketing and sale of the Products, if the parties agree, including but not limited to the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances Act, as amended (21 U.S.C. §801 et seq.), or as defined in attendant regulations promulgated under authorities granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having effect in any jurisdiction in the Territory;",
                "explanation": "By inserting \"some laws\" and \"if the parties agree,\" the definition of Applicable Laws is weakened. This creates ambiguity as to which laws the parties must comply with, contradicting the mandatory nature of regulatory compliance.",
                "contradicted_law": "Federal Food, Drug, and Cosmetic Act (FD&C Act)",
                "law_citation": "21 U.S.C. § 301 et seq.",
                "law_url1": [
                    "https://www.fda.gov/regulatory-information/federal-food-drug-and-cosmetic-act"
                ],
                "law_url2": [
                    "https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-prelim-title21-chapter9&edition=prelim"
                ],
                "law_explanation": "The FD&C Act mandates strict adherence to regulations regarding the safety and efficacy of drugs and medical devices. By suggesting that compliance is optional or selective, the modified text directly contradicts the FD&C Act's requirements, which apply to all entities involved in the manufacture, distribution, and sale of products covered by the Act.",
                "location": "Section 1.1"
            },
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "PPI hereby grants to EKR a royalty free and exclusive license (with the right to sublicense) to use the Trademarks in the Territory solely in connection with the exercise of the Distribution Rights in the Territory during the Term (and thereafter as set forth in Section 17.4) and EKR shall market and sell the Products under the Trademarks.",
                "changed_text": "PPI hereby grants to EKR a royalty free and exclusive license (with the right to sublicense) to use the Trademarks in the Territory solely in connection with the exercise of the Distribution Rights in the Territory during the Term (and thereafter as set forth in Section 17.4) and EKR may market and sell the Products under different marks.",
                "explanation": "By changing \"EKR shall market and sell the Products under the Trademarks\" to \"EKR may market and sell the Products under different marks\" allows the party to market goods using names not owned by the manufacturer, or in conjunction with the trademark use different marks, impacting source identification and goodwill.",
                "contradicted_law": "Lanham Act",
                "law_citation": "15 U.S.C. § 1114",
                "law_url1": [
                    "https://www.law.cornell.edu/uscode/text/15/1114"
                ],
                "law_url2": [
                    "https://www.uspto.gov/ip-policy/summary-federal-laws-related-ip#Lanham"
                ],
                "law_explanation": "The Lanham Act protects trademark owners from the use of their trademarks by unauthorized parties. The modified text allowing EKR to market under 'different marks' dilutes PPI's trademark, which contradicts the Lanham Act's objective to prevent consumer confusion and protect trademark holders.",
                "location": "Section 2.3"
            },
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "Each Party shall maintain, at its own cost, comprehensive product liability insurance, general commercial liability insurance and business interruption insurance at a level which is reasonable and customary taking into account the nature of the Product but which shall have combined limits of not less than $[**] per occurrence. Such insurance shall be with a reputable insurance company and where reasonably possible (taking into account the availability of such insurance) shall be maintained for not less than [**] ([**]) years following the expiry or termination of this Agreement.",
                "changed_text": "Each Party may maintain, at its own discretion, product liability insurance. The amount of coverage, if any, shall be based on internal financial considerations. Such insurance, if purchased, shall be with a company of their choosing and will be maintained at their discretion.",
                "explanation": "Changing \"Each Party shall maintain\" to \"Each Party may maintain\" transforms a mandatory obligation to an optional one. Eliminating the minimum coverage requirement and the reputable insurance company requirement further weakens the provision. This is misaligned because many industries maintain product liability coverage in some form, especially with pharmaceuticals.",
                "contradicted_law": "General Principles of Contract Law",
                "law_citation": "Restatement (Second) of Contracts § 205",
                "law_url1": [
                    "https://www.law.cornell.edu/wex/good_faith"
                ],
                "law_url2": [
                    "https://www.uniformlaws.org/committees/community-home?communitykey=817ad90f-d31f-4993-9f98-b30b946ca3b8"
                ],
                "law_explanation": "Under contract law, parties are expected to act in good faith and with fair dealing. By making product liability insurance optional and removing any standard of reasonableness for the amount or quality of coverage, the modified text enables a party to avoid responsibility for foreseeable damages, violating the principle of good faith.",
                "location": "Section 10.6"
            }
        ]
    }
]